Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Acetaminophen. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.95 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.95 |
| ▸ | MAPT | P10636 | 3/20 | 0.95 |
| ▸ | MEN1 | O00255 | 3/20 | 0.95 |
| ▸ | CA12 | O43570 | 1/20 | 0.95 |
| ▸ | BRD4 | O60885 | 1/20 | 0.95 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.95 |
| ▸ | CA1 | P00915 | 1/20 | 0.95 |
| ▸ | CA2 | P00918 | 1/20 | 0.95 |
| ▸ | MB | P02144 | 1/20 | 0.95 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.95 |
| ▸ | CA3 | P07451 | 1/20 | 0.95 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.95 |
| ▸ | RARG | P13631 | 1/20 | 0.95 |
| ▸ | TSHR | P16473 | 1/20 | 0.95 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.95 |
| ▸ | CA4 | P22748 | 1/20 | 0.95 |
| ▸ | CA7 | P43166 | 1/20 | 0.95 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.95 |
| ▸ | CA9 | Q16790 | 1/20 | 0.95 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetaminophen SCHEMBL8937727 | 0.98 | KMT2A (1.00) | ALDH1A1KMT2AMAPTMEN1CA12 | |
| Acetaminophen SCHEMBL252939 | 0.98 | KMT2A (1.00) | ALDH1A1KMT2AMAPTMEN1CA12 | |
| Acetaminophen SCHEMBL3480 | 0.98 | KMT2A (1.00) | ALDH1A1KMT2AMAPTMEN1CA12 | |
| Acetaminophen SCHEMBL8197085 | 0.95 | KMT2A (0.95) | ALDH1A1KMT2AMAPTMEN1CA12 | |
| Acetaminophen SCHEMBL10325382 | 0.95 | KMT2A (0.95) | ALDH1A1KMT2AMAPTMEN1CA12 | |
| Acetaminophen SCHEMBL5081499 | 0.95 | KMT2A (0.95) | ALDH1A1KMT2AMAPTMEN1CA12 | |
| Acetaminophen SCHEMBL31738441 | 0.95 | KMT2A (0.95) | ALDH1A1KMT2AMAPTMEN1CA12 | |
| Acetaminophen SCHEMBL8959271 | 0.95 | KMT2A (0.95) | ALDH1A1KMT2AMAPTMEN1CA12 | |
| Acetaminophen SCHEMBL8207526 | 0.95 | KMT2A (0.95) | ALDH1A1KMT2AMAPTMEN1CA12 | |
| Acetaminophen SCHEMBL30861435 | 0.95 | KMT2A (0.95) | ALDH1A1KMT2AMAPTMEN1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210338578-A1 | METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF | HYLORIS DEVELOPMENTS SA (BE) | 2021-11-04 | — | — | US | disclosed |
| EP-3612157-A1 | METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF | Hyloris Developments SA (BE) | 2020-02-26 | — | — | EP | disclosed |
| CN-110719773-A | Process for preparing a composition having a low dissolved oxygen content comprising paracetamol and optionally one or more NSAIDs and the composition obtained thereby | 海罗利斯发展公司 | 2020-01-21 | — | — | CN | disclosed |
| WO-2018193099-A1 | METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF | HYLORIS DEVELOPMENTS SA (BE) | 2018-10-25 | — | — | WO | disclosed |
| WO-2018192664-A1 | METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF | HYLORIS DEVELOPMENTS SA (BE) | 2018-10-25 | — | — | WO | disclosed |